Inflammation plays a prominent role in the development of atherosclerosis and other
cardiovascular diseases, and anti-inflammatory agents may improve cardiovascular …

Background Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in
clinical practice. The aim of this review was to evaluate the progress made in the …

Cardiovascular disease (CVD) is the leading cause of death in the world. In 2019, 550
million people were suffering from CVD and 18 million of them died as a result. Most of them …

The prevalence of atrial fibrillation (AF) is bound to increase globally in the following years,
affecting the quality of life of millions of people, increasing mortality and morbidity, and …

Background The role of systemic inflammation in promoting cardiovascular diseases has
attracted attention, but its correlation with various arrhythmias remains to be clarified. We …

Colchicine is an anti-inflammatory medication, classically used to treat a wide spectrum of
autoimmune diseases. More recently, colchicine has proven itself a key pharmacotherapy in …

Background Studies using 1 mg of colchicine to prevent postoperative atrial fibrillation
(POAF) reported conflicting results. Moreover, colchicine was associated with significant …

Colchicum autumnale, from which colchicine has been isolated more than 100 years ago,
has been used as a treatment for pain and swelling for thousands of years. It is one of the …

Objective This study intended to assess the efficacy of colchicine for prevention of post-
operative atrial fibrillation (AF). Background Post-operative AF is a common complication of …

Background Postoperative atrial fibrillation (POAF) is the most common arrhythmia following
cardiac surgery (CS). It may occur between the 1st and the 4th postoperative day as acute …